
Maud Lemarié
PhD in Biomedical Sciences, founder of CRISPRight, expert in gene editing and epigenetics.
Graduated with a doctorate from the University of Montreal, I initially explored the transcriptional mechanisms of the IKAROS factor in human and murine hematopoietic cells. Subsequently, my research allowed me to study the role and regulation of CAVEOLIN-1, a structural protein, during human B lymphocytes development. Over these ten years of research, I have developed an advanced expertise in cellular and molecular biology, particularly in CRISPR-Cas9 technologies and epigenetic approaches.
Passionate about knowledge transfer, I have applied my academic experience to innovative companies, advising them on R&D/Innovation project setup and access to national funding.
My approach combines scientific rigor with operational pragmatism:
- Strategic design of CRISPR and epigenetic projects
- Development, optimization, and validation of bench protocols
- Practical training of teams and skills transfer
- Support in writing (articles, reviews, grant applications)
My mission is to relieve you of technical and administrative complexities so that you can focus your energy on innovation and discoveries.
Want to give a new boost to your projects? Contact me to discuss your needs and build customized solutions together.
